Skip to content

Mobilization With Movement on Pain, Function, and Quality of Life in Patients With Thoracic Outlet Syndrome

The Impact of Mobilization With Movement on Pain, Function, and Quality of Life in Patients With Thoracic Outlet Syndrome: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05917756
Enrollment
120
Registered
2023-06-26
Start date
2023-07-01
Completion date
2024-07-01
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Outlet Syndrome

Brief summary

This randomized controlled trial aims to evaluate the effects of Mobilization with Movement (MWM) on pain, function, and quality of life in patients with Thoracic Outlet Syndrome (TOS) compared to conventional physiotherapy.

Interventions

OTHERMobilization with Movement (MWM) and Tailored Therapeutic Exercise Program

The intervention consists of MWM techniques targeting the cervical and thoracic spine, and the first rib, applied by a certified physiotherapist for 8 weeks, 2 sessions per week, each session lasting 45 minutes. The intervention also includes a tailored therapeutic exercise program for the patients, comprising postural correction, stretching, and strengthening exercises. This intervention will be compared to conventional physiotherapy in the control group.

OTHERConventional Physiotherapy

Conventional physiotherapy, including manual therapy (soft tissue mobilization, joint mobilization, and nerve gliding techniques) for 8 weeks, 2 sessions per week, each session lasting 45 minutes, combined with a tailored therapeutic exercise program (including postural correction, stretching, and strengthening exercises).

Sponsors

Ahram Canadian University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Two-arm randomized controlled trial with an equal allocation ratio (1:1) for the experimental and control groups

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-65 years, diagnosed with TOS by a specialist, and experiencing symptoms for at least 3 months

Exclusion criteria

* Previous surgery for TOS * contraindications to manual therapy * other comorbidities significantly affecting upper limb function

Design outcomes

Primary

MeasureTime frameDescription
Changes in Pain IntensityChanges in Pain intensity at Baseline, 4 weeks, 8 weeks, and 12 weeks (follow-up)Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS).

Secondary

MeasureTime frameDescription
Changes in Functional StatusChanges in Functional Status Baseline, 4 weeks, 8 weeks, and 12 weeks (follow-up)Functional status will be evaluated using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire.
Changes in Cervical Range of MotionBaseline, 4 weeks, 8 weeks, and 12 weeks (follow-up)Cervical range of motion will be assessed using a goniometer.
Changes in Quality of LifeChanges in quality of life at Baseline, 4 weeks, 8 weeks, and 12 weeks (follow-up)aseline, 4 weeks, 8 weeks, and 12 weeks (follow-up)Quality of life will be assessed using the Short Form-36 (SF-36) questionnaire

Countries

Egypt

Contacts

Primary ContactMohamed M ElMeligie, Ph.d
mohamed.elmeligie@acu.edu.eg+201064442032

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026